The ACC recognises the research into cardiotoxicity carried out at the CNIC by Danielle Medina-Hernández
The Young Author Achievement Award recognises her research into cardiotoxicity published in JACC: Cardio-Oncology
Researcher Danielle Medina Hernández, from Wake Forest University School of Medicine, who was part of the group led by Dr Borja Ibáñez at the Carlos III National Centre for Cardiovascular Research (CNIC), has been awarded the JACC: CardioOncology 2025 Young Author Award by the American College of Cardiology (ACC). This award recognises the scientific excellence of young authors whose contributions have had a significant impact in the field of cardiovascular research.
This award recognises her outstanding contribution to the field of cardiovascular medicine through the article entitled “SGLT2i Therapy Prevents Anthracycline-Induced Cardiotoxicity in a Large Animal Model by Preserving Myocardial Energetics”, published in JACC: Cardio-Oncology in February 2025.
The JACC: CardioOncology Young Author Award recognises the exceptional scientific rigour, originality and clinical relevance of the selected papers. The award reflects not only the quality of the published research, but also the author’s emerging leadership and her impact on the cardiovascular community.
This award highlights the quality and relevance of the research carried out by Dr Medina Hernández during her time at the CNIC, as well as her contribution to the advancement of knowledge in cardiology. Furthermore, this recognition underscores the CNIC’s strong research and mentoring environment, which fosters the development of high-calibre work and the advancement of cardiovascular science.
Dr Medina Hernández received the award during a special ceremony held as part of the ACC Annual Meeting 2026 in New Orleans.
